DISEASE HISTORY OF A COMORBID PATIENT

  • Вовк К.В. к. мед. н., медичний факультет, Харківський національний університет імені В. Н. Каразіна, м. Харків, Україна
  • Шерстюк Л.Л. к. мед. н., медичний факультет, Харківський національний університет імені В. Н. Каразіна, м. Харків, Україна
  • Власенко О.О. к. мед. н., медичний факультет, Харківський національний університет імені В. Н. Каразіна, м. Харків, Україна
  • Адамович І.В. медичний факультет, Харківський національний університет імені В. Н. Каразіна, м. Харків, Україна
Keywords: Comorbid Pathology, Polypharmacy, Therapy

Abstract

In real clinical practice, more and more doctors encounter comorbid pathology. The combination of cardiovascular diseases with the pathology of other internal organs dictates the need to prescribe a variety of drugs. A comorbid patient is a serious problem for any clinician, since in this case it is necessary to take into account several components of therapy, which makes it difficult to control the effectiveness of the treatment, increases polypharmacy, the likelihood of developing local and systemic side effects of drugs, and also reduces adherence to therapy. The article presents a discussion of the clinical case of a comorbid patient, which required a broad outlook of the therapist in the field of not only cardiological aspects of diagnosis and treatment, but also nephrological, rheumatological. The stages of the performed diagnostic search with the verification of the clinical diagnosis and the tactics of the prescribed pharmacotherapy are given. Based on the presented data, it is shown that in conditions of comorbidity it is difficult for a doctor to avoid polypharmacy. We present to your attention a clinical observation in which combined independent clinical conditions acquire the character of comorbid processes, determining the difficult situation of choosing a rational therapy.

References

Robinson PC. Gout - An update of aetiology, genetics, co-morbidities and management./ Maturitas. 2018 Dec;118 - P. 67-73. https://www.maturitas.org/article/S0378-5122(18)30537-1/fulltext.

Thomas Bardin, Pascal Richette Impact of comorbidities on gout and hyperuricaemia: an update on prevalence and treatment options / BMC Medicine (2017) 15 – P. 123 https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-017-0890-9.

Lisa K. Stamp, Peter T. Chapman Gout and its comorbidities: implications for therapy Rheumatology 2013;52 - P. 34 – 44 https://academic.oup.com/rheumatology/article/52/1/34/1828253.

Chang-Fu Kuo, Matthew J Grainge, Christian Mallen, Weiya Zhang, Michael Doherty Comorbidities in patients with gout prior to and following diagnosis: case-control study/ Rheum Dis 2016;75 – P. 210–217. https://ard.bmj.com/content/annrheumdis/75/1/210.full.pdf.

Jonas Hoffmann, Burkhard Haastert, Manuela Brüne, Matthias Kaltheuner, Alexander Begun, Nadja Chernyak, Andrea Icks How do patients with diabetes report their comorbidity? Comparison with administrative data/ Clinical Epidemiology 2018:10 – P. 499–509 https://www.dovepress.com/getfile.php?fileID=41791.

Views:

106

Downloads:

89

Published
2023-06-09
Citations
How to Cite
Вовк К.В., Шерстюк Л.Л., Власенко О.О., & Адамович І.В. (2023). DISEASE HISTORY OF A COMORBID PATIENT. World Science, (2(80). https://doi.org/10.31435/rsglobal_ws/30062023/7993
Section
Medicine